REporting recommendations for tumour MARKer prognostic studies (REMARK)

European Journal of Cancer

Volumn 41, Issue 12, 2005, Pages 1690-1696

  McShane, Lisa M ^a   Altman, Douglas G ^a   Sauerbrei, Willi ^a   Taube, Sheila E ^a   Gion, Massimo ^a   Clark, Gary M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EORTC; Guidelines; NCI; Prognostic; REMARK; Tumour markers

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RESEARCH; MEDICAL INFORMATION; MEDICAL RESEARCH; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; TUMOR;

BIOMEDICAL RESEARCH; HUMANS; INFORMATION DISSEMINATION; NEOPLASMS; RESEARCH DESIGN; TUMOR MARKERS, BIOLOGICAL;

EID: 23644432019     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.03.032     Document Type: Article

References (42)

1. D.F. Hayes, R.C. Bast, and C.E. Desch Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers J Natl Cancer Inst 88 1996 1456 1466
2. R.C. Bast Jr., P. Ravdin, and D.F. Hayes American Society of Clinical Oncology Tumor Markers Expert Panel. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 2001 1865 1878
3. R.L. Schilsky, and S.E. Taube Introduction: tumor markers as clinical cancer tests - are we there yet? Semin Oncol 29 2002 211 212
4. W.L. McGuire Breast cancer prognostic factors: evaluation guidelines J Natl Cancer Inst 83 1991 154 155
5. L.P. Fielding, C.M. Fenoglio-Preiser, and L.S. Freedman The future of prognostic factors in outcome prediction for patients with cancer Cancer 70 1992 2367 2377
6. H.B. Burke, and D.E. Henson Criteria for prognostic factors and for an enhanced prognostic system Cancer 72 1993 3131 3135
7. J. Concato, A.R. Feinstein, and T.R. Holford The risk of determining risk with multivariable models Ann Intern Med 118 1993 201 210
8. G. Gasparini, F. Pozza, and A.L. Harris Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients J Natl Cancer Inst 85 1993 1206 1219
9. R. Simon, and D.G. Altman Statistical aspects of prognostic factor studies in oncology Br J Cancer 69 1994 979 985
10. G. Gasparini Prognostic variables in node-negative and node-positive breast cancer Breast Cancer Res Treat 52 1998 321 331
11. P.A. Hall, and J.J. Going Predicting the future: a critical appraisal of cancer prognosis studies Histopathology 35 1999 489 494
12. J.A. Hoppin, P.E. Tolbert, and J.A. Taylor Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies Ann Epidemiol 12 2002 1 6
13. A.D. Thor, S. Liu, and D.H. Moore II Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer J Clin Oncol 17 1999 470 477
14. D. Gancberg, L. Lespagnard, and G. Rouas Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases Am J Clin Pathol 113 2000 675 682
15. L.M. McShane, R. Aamodt, C. Cordon-Cardo and the National Cancer Institute Bladder Tumor Marker Network Reproducibility of p53 immunohistochemistry in bladder tumors Clin Cancer Res 6 2000 1854 1864
16. S. Paik, J. Bryant, and E. Tan-Chiu Real-world performance of HER2 testing - National Surgical Adjuvant Breast and Bowel Project Experience J Natl Cancer Inst 94 2002 852 854
17. P.C. Roche, V.J. Suman, and R.B. Jenkins Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831 J Natl Cancer Inst 94 2002 855 857
18. D.G. Altman, B.L. De Stavola, and S.B. Love Review of survival analyses published in cancer journals Br J Cancer 72 1995 511 518
19. M.D. Brundage, D. Davies, and W.J. Mackillop Prognostic factors in non-small cell lung cancer: a decade of progress Chest 122 2002 1037 1057
20. A.N. Mirza, N.Q. Mirza, and G. Vlastos Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years Ann Surg 235 2002 10 26
21. R.D. Riley, K.R. Abrams, and A.J. Sutton Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future Br J Cancer 88 2003 1191 1198
22. R.D. Riley, S.A. Burchill, and K.R. Abrams A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family Eur J Cancer 39 2003 19 30
23. A. Burton, and D.G. Altman Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines Br J Cancer 91 2004 4 8
24. S. Popat, A. Matakidou, and R.S. Houlston Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis J Clin Oncol 22 2004 529 536
25. R.D. Riley, D. Heney, and D.R. Jones A systematic review of molecular and biological tumor markers in neuroblastoma Clin Cancer Res 10 2004 4 12
26. D.G. Altman, and G.H. Lyman Methodological challenges in the evaluation of prognostic factors in breast cancer Breast Cancer Res Treat 52 1998 289 303
27. M. Gion, P. Boracchi, and E. Biganzoli A guide for reviewing submitted manuscripts (and indications for the design of translational research studies on biomarkers) Int J Biol Markers 14 1999 123 133
28. D.G. Altman Systematic reviews of evaluations of prognostic variables M. Egger G. Smith Davey D.G. Altman Systematic reviews in health care. Meta-analysis in context 2nd ed. 2001 BMJ Books London 228 247
29. D.G. Altman Systematic reviews of evaluations of prognostic variables BMJ 323 2001 224 228
30. L.M. McShane, and R. Simon Statistical methods for the analysis of prognostic factor studies M.K. Gospodarowicz D.E. Henson R.V.P. Hutter B. O'Sullivan L.H. Sobin Ch. Wittekind Prognostic factors in cancer 2nd ed. 2001 Wiley-Liss New York 37 48
31. R. Simon Evaluating prognostic factor studies M.K. Gospodarowicz D.E. Henson R.V.P. Hutter B. O'Sullivan L.H. Sobin Ch. Wittekind Prognostic factors in cancer 2nd ed. 2001 Wiley-Liss New York 49 56
32. E. Biganzoli, P. Boracchi, and E. Marubini Biostatistics and tumor marker studies in breast cancer: Design, analysis and interpretation issues Int J Biol Markers 18 2003 40 48
33. Schumacher M, Holländer N, Schwarzer G, Sauerbrei W. Prognostic factor studies. In: Crowley J, editor. Handbook of statistics in clinical oncology, Chapter 18, pp. 307-351. New York: CRC Press.
34. D. Moher, K.F. Schulz, D. Altman for the CONSORT Group The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials JAMA 285 2001 1987 1991
35. P.M. Bossuyt, J.B. Reitsma, and D.E. Bruns Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy Clin Chem 49 2003 1 6
36. D.G. Altman, B. Lausen, and W. Sauerbrei Dangers of using "optimal" cutpoints in the evaluation of prognostic factors J Natl Cancer Inst 86 1994 829 835
37. S.G. Hilsenbeck, G.M. Clark, and W.L. McGuire Why do so many prognostic factors fail to pan out Breast Cancer Res Treat 22 1992 197 206
38. D. Moher, D.J. Cook, S. Eastwood for the QUOROM Group Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Lancet 354 1999 1896 1900
39. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
40. M.E. Hammond, and S.E. Taube Issues and barriers to development of clinically useful tumor markers: a development pathway proposal Semin Oncol 29 2002 213 221
41. D.G. Altman, K.F. Schulz, D. Moher CONSORT Group The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann Intern Med 134 2001 663 694
42. P.M. Bossuyt, J.B. Reitsma, and D.E. Bruns Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration Clin Chem 49 2003 7 18